Updated: Apr 12
Through Pideka, a company created in Colombia that is part of the Canadian international holding company Ikanik Farms
SALOMÓN ASMAR SOTO - SASMAR@LAREPUBLICA.COM.CO Monday, March 8, 2021
The Pideka company announced that it carried out the first commercial shipment of medicinal cannabis with THC from its indoor crops in Tocancipá to Mexico; a destination that can represent a market of US $ 20,000 million and that has about a million potential patients suitable for treatments with these components.
“This is a very important step that we have been able to take with the help of ProColombia and other entities of the Government of Colombia, so it opens the door to consolidate ourselves in a market as important as Mexico, to sell oil to the public or private sector. of medicinal cannabis with THC, "said Borja Sanz de Madrid, president of Pideka, a company created in Colombia that is part of the Canadian international holding company Ikanik Farms and has Canadian, Spanish, North American and Latin American investment.
This product, he indicated, can serve the pharmaceutical industry to combat four fronts: chronic pain such as arthritis, different types of epilepsy, insomnia, stress and anxiety, and to reduce the side effects of chemotherapy in cancer treatments.
The Mexican client chose this product of origin from Colombia for production, quality and legislation, Sanz stressed.
For its part, ProColombia stated that it has been working for several years with the industry, "supporting it in terms of regulation, investment promotion, exports and identification of opportunities in markets where regulation allows access to these products, as in the case of Germany and the United Kingdom ".
For this reason, the entity has developed medical cannabis profiles in destinations such as Germany, Peru, the United States, Spain, the United Kingdom and Brazil.
The businessman estimates that in the next two to three years they may be exporting from Colombia between US $ 80 million and US $ 100 million in medicinal cannabis with THC, taking into account that a liter of the product can cost about US $ 45,000.
"This is a conservative range, based on the amount of liters we have per year, which we will gradually increase. We see a great demand in Mexico and we aim to also serve the European market, where we have already seen the interest from pharmaceutical companies in Denmark and England. Once Asia begins to have its first legalizations, it can be a very important continent in terms of demand. In this sense, we aim for it to be one of the main players worldwide, thanks to our efficiency model ”, indicated the president of Pideka, a company with a little more than 30 employees and which expects to reach 150 positions in 2022.
According to Dane figures, between January and November 2020, the United States, the United Kingdom, Australia, Israel, Germany and Switzerland were the countries that bought the most medical cannabis from Colombia. The jump has been exponential since, in that period, exports went from US $ 275,000 in 2019 to US $ 4.7 million, with a growth of more than 1,600%.